Zobrazeno 1 - 10
of 371
pro vyhledávání: '"Jin Hyoung, Kang"'
Autor:
Hye Ryun Kim, Shunichi Sugawara, Jong‐Seok Lee, Jin‐Hyoung Kang, Naoki Inui, Toyoaki Hida, Ki Hyeong Lee, Tatsuya Yoshida, Hiroshi Tanaka, Cheng‐Ta Yang, Makoto Nishio, Yuichiro Ohe, Tomohide Tamura, Nobuyuki Yamamoto, Chong‐Jen Yu, Hiroaki Akamatsu, Shigeru Takahashi, Kazuhiko Nakagawa
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 17061-17067 (2023)
Abstract Background ONO‐4538‐52/TASUKI‐52 was performed in Japan, Korea, and Taiwan to determine the oncological effectiveness and safety of combining nivolumab or placebo with bevacizumab plus platinum chemotherapy for the initial (first‐lin
Externí odkaz:
https://doaj.org/article/b0fcd685eeec41798eee2fd83380a4ba
Autor:
Der Sheng Sun, Yoon Ho Ko, Jong Youl Jin, In Sook Woo, Suk Young Park, Yun Ae Eom, Jin Hyoung Kang, Hoon Kyo Kim
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 3, Pp 406-416 (2023)
Background/Aims We compared the efficacy of the granisetron transdermal system (GTS) with that of ondansetron for controlling chemotherapy-induced nausea and vomiting (CINV) in patients treated with highly emetogenic chemotherapy (HEC). Methods We ra
Externí odkaz:
https://doaj.org/article/6cbaec29d6c3464081c63bf2848ce1b1
Autor:
Young-Woong Won1 wonhero@hanyang.ac.kr, Jin-Hyoung Kang2, Jung Hye Kwon3, Dong-Hoe Koo4, Jung Hun Kang5, Chi Hoon Maeng6, Hee Kyung Ahn7, Sung Yong Oh8, Dae-Won Lee9, Joohyuk Sohn10, So Yeon Oh11, Kyung Hee Lee12, Su-Jin Koh13, Keun Seok Lee14, Chan-Kyu Kim15, Ji-Yeon Kim16, Jun Ho Ji17, Sung-Bae Kim18, Joo Young Ha19, Ho Young Kim20
Publikováno v:
Cancer Research & Treatment. Oct2023, Vol. 55 Issue 4, p1096-1103. 8p.
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Purpose Rapid development of novel therapeutics in renal cell carcinoma (RCC) has led to financial burden for patients and society. Value including clinical benefit, toxicity affecting quality of life and cost-effectiveness are a concern, pr
Externí odkaz:
https://doaj.org/article/5ebb2c7cee7447a9a69e3a5b75c0ca62
Autor:
Keunchil Park, Jin-Soo Kim, Joo-Hang Kim, Young-Chul Kim, Hoon-Gu Kim, Eun Kyung Cho, Jong-Youl Jin, Miyoung Kim, Angela Märten, Jin-Hyoung Kang
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Afatinib is approved globally for EGFR-TKI treatment-naïve patients with EGFR mutation-positive non-small cell lung cancer (NSCLC). In this Korean expanded access program, we evaluated its ‘real-world’ safety and efficacy. Me
Externí odkaz:
https://doaj.org/article/5eec3f88da44408eabe8ce0a99337a67
Autor:
HYUNHO KIM, UIJU CHO, SOOK HEE HONG, HYUNG SOON PARK, IN-HO KIM, HO JUNG AN, BYOUNG YONG SHIM, JIN HYOUNG KANG
Publikováno v:
Oncology Research; 2024, Vol. 32 Issue 6, p1021-1030, 10p
Autor:
Seo Ree Kim, Sang Hoon Chun, Joo Ri Kim, Sang-Yeob Kim, Jun Young Seo, Chan Kwon Jung, Bo-Mi Gil, Jeong-Oh Kim, Yoon Ho Ko, In Sook Woo, Byoung Yong Shim, Sook-Hee Hong, Jin Hyoung Kang
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Immune checkpoint blockades (ICBs) are characterized by a durable clinical response and better tolerability in patients with a variety of advanced solid tumors. However, we not infrequently encounter patients with hyperprogressive
Externí odkaz:
https://doaj.org/article/af7c81e1bb04464fa55c054aae8776d3
Autor:
Min-Young Kim, Jung-Young Shin, Jeong-Oh Kim, Kyoung-Hwa Son, Yeon Sil Kim, Chan Kwon Jung, Jin-Hyoung Kang
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background Hypoxic tumors are known to be highly resistant to radiotherapy and cause poor prognosis in non-small cell lung cancer (NSCLC) patients. CKD-516, a novel vascular disrupting agent (VDA), mainly affects blood vessels in the central
Externí odkaz:
https://doaj.org/article/4378f3f5e1e8448784237686d3099f49
Autor:
Kyu Hye Choi, Jin Ho Song, Ji Hyun Hong, Youn Soo Lee, Jin Hyoung Kang, Dong-Il Sun, Min-Sik Kim, Yeon-Sil Kim
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0273059 (2022)
ObjectivesThe pathologic nodal stage of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) patients is classified according to the number of lymph nodes (LNs), as revised in 2018. Previous studies showed that the LN ratio (LNR) could be al
Externí odkaz:
https://doaj.org/article/2d00f12b532341908cf8ae0ed6e0888d
Autor:
Seo Ree Kim, Sang Hoon Chun, Ji Hyun Kim, Sang-Yeob Kim, Bo-In Lee, Chan Kwon Jung, Jin Hyoung Kang
Publikováno v:
Korean Journal of Clinical Oncology, Vol 16, Iss 1, Pp 57-62 (2020)
Recent data showed that DNA mismatch repair deficiency can be a predictive biomarker for a favorable response of immune checkpoint inhibitors regardless of tumor type due to give rise to high tumor mutational burden (TMB) and microsatellite instabili
Externí odkaz:
https://doaj.org/article/026aff21bac84bd9849f44aaab221385